Evidence map›Paper›PMID 38037525›Full record

ArticleClinical and translational medicine2023

Single-cell profiling reveals tumour cell heterogeneity accompanying a pre-malignant and immunosuppressive microenvironment in gastric adenocarcinoma.

Jie Ge, Xiao Xiao, Haiyan Zhou, Mimi Tang, Jing Bai, Xinchen Zou, Chunliu Zhang, Changhao Huang, Xiang Feng, Ting Liu and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jie GeDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xiao XiaoGenomics Institute, Geneplus-Shenzhen, Shenzhen, China.
Haiyan ZhouDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Mimi TangInstitute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Jing BaiGeneplus-Beijing Institute, Beijing, China.
Xinchen ZouGeneplus-Beijing Institute, Beijing, China.
Chunliu ZhangGeneplus-Beijing Institute, Beijing, China.
Changhao HuangThe Hunan Provincial Key Laboratory of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha, China.
Xiang FengDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Ting LiuDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xin YiGeneplus-Beijing Institute, Beijing, China.
Xuefeng XiaGeneplus-Beijing Institute, Beijing, China.
Heli LiuDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Zihua ChenDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.ORCID 0000-0002-8467-7742

Funding

Guangdong Yiyang Healthcare Charity Foundation JZ2022014Hunan Province Science and Technology Innovation Plan Project 2018SK52604National Natural Science Foundation of China 8197103463
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaStomach NeoplasmsHumansTumor Microenvironment

Identifiers

PMID38037525
PMCPMC10689970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.